Your browser doesn't support javascript.
loading
Idelalisib inhibits experimental proliferative vitroretinopathy.
Dong, Lijun; Han, Haote; Huang, Xionggao; Ma, Gaoen; Fang, Dong; Qi, Hui; Han, Zhuo; Wang, Luping; Tian, Jingkui; Vanhaesebroeck, Bart; Zhang, Guoming; Zhang, Shaochong; Lei, Hetian.
Afiliación
  • Dong L; Shenzhen Eye Hospital, Jinan University, Shenzhen Eye Institute, Shenzhen, China.
  • Han H; Institute of Cancer and Basic Medicine, Chinese Academy of Sciences, Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, China.
  • Huang X; Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, MA, USA.
  • Ma G; Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.
  • Fang D; Department of Ophthalmology, the First Affiliated Hospital of Hainan Medical University, Haikou, China.
  • Qi H; Department of Ophthalmology, the third Hospital of Xinxiang Medical University, Xinxiang, China.
  • Han Z; Shenzhen Eye Hospital, Jinan University, Shenzhen Eye Institute, Shenzhen, China.
  • Wang L; Shenzhen Eye Hospital, Jinan University, Shenzhen Eye Institute, Shenzhen, China.
  • Tian J; Institute of Cancer and Basic Medicine, Chinese Academy of Sciences, Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, China.
  • Vanhaesebroeck B; Institute of Cancer and Basic Medicine, Chinese Academy of Sciences, Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, China.
  • Zhang G; Institute of Cancer and Basic Medicine, Chinese Academy of Sciences, Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, China.
  • Zhang S; Cancer Institute, University College London, London, UK.
  • Lei H; Shenzhen Eye Hospital, Jinan University, Shenzhen Eye Institute, Shenzhen, China.
Lab Invest ; 102(12): 1296-1303, 2022 12.
Article en En | MEDLINE | ID: mdl-35854067

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Fibronectinas / Vitreorretinopatía Proliferativa Límite: Animals / Humans Idioma: En Revista: Lab Invest Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Fibronectinas / Vitreorretinopatía Proliferativa Límite: Animals / Humans Idioma: En Revista: Lab Invest Año: 2022 Tipo del documento: Article País de afiliación: China